Sepsis-induced cardiomyopathy: understanding pathophysiology and clinical implications
Archives of Toxicology · 2025-02 · 99 (2) · 467-480
DOI: 10.1007/s00204-024-03916-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Archives of Toxicology, online erschienen am 27.11.2024. Verfasst von Haoran Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Emergency and Trauma College, Hainan Medical University, Haikou, People's Republic of China. Hauptthemen laut MEDLINE: Sepsis, Cardiomyopathies. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 138 Literaturangaben. Gefördert von: National Outstanding Youth Science Fund Project of National Natural Science Foundation of China, Natural Science Foundation of Sichuan Province, Postdoctoral Research Foundation of China.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening form of organ dysfunction resulting from a dysregulated response to infection. The complex pathogenesis of sepsis poses challenges because of the lack of reliable biomarkers for early identification and effective treatments. As sepsis progresses to severe forms, cardiac dysfunction becomes a major concern, often manifesting as ventricular dilation, a reduced ejection fraction, and a diminished contractile capacity, known as sepsis-induced cardiomyopathy (SIC). The absence of standardized diagnostic and treatment protocols for SIC leads to varied criteria being used across medical institutions and studies, resulting in significant outcome disparities. Despite the high prevalence of SIC, accurate statistical data are lacking. To understand how SIC affects sepsis prognosis, a thorough exploration of its pathophysiological mechanisms, including systemic factors and complex signalling within myocardial and immune cells, is required. Identifying the factors influencing SIC occurrence and progression is crucial and must be conducted within specific clinical contexts. In this review, the clinical manifestations, pathophysiological mechanisms, and treatment strategies for SIC are discussed, along with the clinical background. We aim to connect current practices with future research challenges, providing clear guidance for clinicians and researchers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Emergency and Trauma College, Hainan Medical University, Haikou, People's Republic of China.
- School of Medicine, Jiangsu University, Zhenjiang, 212001, Jiangsu Province, People's Republic of China.
- Division of Cardiology, Department of Medicine, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, People's Republic of China.
- Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, People's Republic of China.
- Emergency Medicine Center, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, People's Republic of China. young0416@163.com.
ORCID-Profile: Haoran Liu, Chaoqun Xu, Qin Hu, Yang Wang
Förderung
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province
- Postdoctoral Research Foundation of China
- Health Department of Sichuan Province
Zitieren
APA
Liu, H., Xu, C., Hu, Q., & Wang, Y. (2025). Sepsis-induced cardiomyopathy: understanding pathophysiology and clinical implications. Archives of Toxicology, 99(2), 467-480. https://doi.org/10.1007/s00204-024-03916-x
Vancouver
Liu H, Xu C, Hu Q, Wang Y. Sepsis-induced cardiomyopathy: understanding pathophysiology and clinical implications. Archives of Toxicology. 2025;99(2):467-480. doi:10.1007/s00204-024-03916-x
BibTeX
@article{Liu2025,
author = {Liu, Haoran and Xu, Chaoqun and Hu, Qin and Wang, Yang},
title = {Sepsis-induced cardiomyopathy: understanding pathophysiology and clinical implications},
journal = {Archives of Toxicology},
year = {2025},
volume = {99},
number = {2},
pages = {467--480},
doi = {10.1007/s00204-024-03916-x}
}
EUVIMED